Metraipolis › archive › dc_eaa0f6bea302
Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review — Europe PMC PMID:42357368
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42357368
- DOI
- 10.3390/pharmaceutics18060752
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-19T08:08:26.204Z
- SHA-256 of the archived text
cd38d002271031f62b714615f3fab488817af740cebf39278853b399912acb85- Stable URL of this page
https://metraipolis.com/documento/dc_eaa0f6bea302
How to cite
Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review — Europe PMC PMID:42357368 — Europe PMC (en), https://europepmc.org/article/MED/42357368 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_eaa0f6bea302 (Metraipolis archive dc_eaa0f6bea302, sha256 cd38d002271031f62b714615f3fab488817af740cebf39278853b399912acb85)
BibTeX
@misc{dceaa0f6bea302,
title = {Genetic Interruption of PD-1/PD-L1 as an Alternative Means for Immune Checkpoint Blockade in Cancer: A Review — Europe PMC PMID:42357368},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42357368},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_eaa0f6bea302; sha256 cd38d002271031f62b714615f3fab488817af740cebf39278853b399912acb85},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42357368. Agents can read the archived copy with the MCP tool read_document.